Previous 10 | Next 10 |
Evolent Health (NYSE:EVH) is scheduled to announce Q4 earnings results on Wednesday, Feb. 23, after market close. The consensus EPS estimate is $0.01 (vs. -$0.01 in the year-ago period) and the consensus revenue estimate is $236.48M (-13% Y/Y). Over the last 2 years, EVH has beaten EPS estima...
Evolent Health Named One of the Best Places to Work for LBGTQ+ Equality for Second Consecutive Year PR Newswire WASHINGTON , Jan. 27, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrativ...
Evolent Health, Inc. to Release Fourth Quarter and Full Year 2021 Operating Results and Host Conference Call on Wednesday, February 23, 2022 PR Newswire WASHINGTON , Jan. 25, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care compan...
Evolent Health Partners with Minority-Owned Business to Support Medicaid Plan Operations in Cook County, Ill. PR Newswire WASHINGTON , Jan. 24, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administ...
Evolent Health Appoints Seth R. Frank as Vice President, Investor Relations PR Newswire WASHINGTON , Dec. 1, 2021 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a health care company that delivers proven clinical and administrative solutions to pay...
Evolent Health (EVH +5.1%) is trading higher after JP Morgan upgraded the health tech company to Overweight from Neutral, citing its undervaluation compared to industry peers. The price target raised to $37 from $26 per share indicates a premium of ~33% to the last close. After a meeting with...
Evolent Health to Host Oncology Care Panel on Thursday, November 18, 2021 PR Newswire WASHINGTON , Nov. 16, 2021 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a health care company that delivers proven clinical and administrative solutions to...
Image source: The Motley Fool. Evolent Health (NYSE: EVH) Q3 2021 Earnings Call Nov 03, 2021 , 5:30 p.m. ET Operator Continue reading For further details see: Evolent Health (EVH) Q3 2021 Earnings Call Transcript
Evolent Health, Inc. (EVH) Q3 2021 Earnings Conference Call November 3, 2021 5:30 PM ET Company Participants Seth Blackley - Chief Executive Officer John Johnson - Chief Financial Officer Conference Call Participants Ryan Daniels - William Blair Sean Wieland - Piper Sandler Charles Rhyee - Co...
Evolent Health (NYSE:EVH): Q3 GAAP EPS of -$0.44 misses by $0.28. Revenue of $222.47M (-7.1% Y/Y) misses by $3.09M. Press Release For further details see: Evolent Health EPS misses by $0.28, misses on revenue
News, Short Squeeze, Breakout and More Instantly...
Evolent Health Inc Class A Company Name:
EVH Stock Symbol:
NYSE Market:
2024-04-19 10:47:02 ET Intel Corp. (INTC) INTC is trading DOWN for the last 4 days, and it at trading at $34.86 with volume of 14,560,236 and a one day change of $-0.18 (-0.51%). Intel Corp. has a 52-week low of 26.86 and a 52-week high of $51.28. The business's 50-day moving averag...
Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024 PR Newswire Company to Participate in Upcoming Conferences WASHINGTON , April 18, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better ...
2024-04-17 14:30:04 ET Piper Sandler analyst issues OVERWEIGHT recommendation for EVH on April 17, 2024 12:15PM ET. The previous analyst recommendation was Overweight. EVH was trading at $29.6 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...